Anne Gussow

Array ( [id] => 5215636 [patent_doc_number] => 20070104717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Compositions and methods for detecting and treating cancer' [patent_app_type] => utility [patent_app_number] => 11/519248 [patent_app_country] => US [patent_app_date] => 2006-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 36432 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20070104717.pdf [firstpage_image] =>[orig_patent_app_number] => 11519248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367162 [patent_doc_number] => 20090304721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'TOXIN CONJUGATED EPH RECEPTOR ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/065832 [patent_app_country] => US [patent_app_date] => 2006-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 71 [patent_figures_cnt] => 71 [patent_no_of_words] => 64914 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304721.pdf [firstpage_image] =>[orig_patent_app_number] => 12065832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5142414 [patent_doc_number] => 20070004630 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology' [patent_app_type] => utility [patent_app_number] => 11/517599 [patent_app_country] => US [patent_app_date] => 2006-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 19985 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004630.pdf [firstpage_image] =>[orig_patent_app_number] => 11517599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5182529 [patent_doc_number] => 20070053873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'CANINE TUMOR TREATMENT METHOD, PHARMACEUTICAL FORMULATION APPLIED THERETO, AND METHOD OF CRYOGENICALLY PRESERVING CELLS USED THEREWITH' [patent_app_type] => utility [patent_app_number] => 11/465892 [patent_app_country] => US [patent_app_date] => 2006-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5720 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20070053873.pdf [firstpage_image] =>[orig_patent_app_number] => 11465892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5107676 [patent_doc_number] => 20070066554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Immunostimulatory nucleic acids' [patent_app_type] => utility [patent_app_number] => 11/507079 [patent_app_country] => US [patent_app_date] => 2006-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 55659 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20070066554.pdf [firstpage_image] =>[orig_patent_app_number] => 11507079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 217271 [patent_doc_number] => 07612181 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-03 [patent_title] => 'Dual variable domain immunoglobulin and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/507050 [patent_app_country] => US [patent_app_date] => 2006-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 56779 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/612/07612181.pdf [firstpage_image] =>[orig_patent_app_number] => 11507050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4692739 [patent_doc_number] => 20080085510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-10 [patent_title] => 'HUMAN RON-RELATED GENE VARIANT ASSOCIATED WITH CANCERS' [patent_app_type] => utility [patent_app_number] => 11/465308 [patent_app_country] => US [patent_app_date] => 2006-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 6379 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20080085510.pdf [firstpage_image] =>[orig_patent_app_number] => 11465308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5086078 [patent_doc_number] => 20070276129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Modular molecular clasps and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/505630 [patent_app_country] => US [patent_app_date] => 2006-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19280 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20070276129.pdf [firstpage_image] =>[orig_patent_app_number] => 11505630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792132 [patent_doc_number] => 20080293106 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Method For the Mass Production of Immunoglobulin Fc Region Deleted Initial Methionine Residues' [patent_app_type] => utility [patent_app_number] => 12/063379 [patent_app_country] => US [patent_app_date] => 2006-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14809 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293106.pdf [firstpage_image] =>[orig_patent_app_number] => 12063379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5106590 [patent_doc_number] => 20070065467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Immunostimulatory nucleic acid molecules for activating dendritic cells' [patent_app_type] => utility [patent_app_number] => 11/503377 [patent_app_country] => US [patent_app_date] => 2006-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 18097 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20070065467.pdf [firstpage_image] =>[orig_patent_app_number] => 11503377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 103145 [patent_doc_number] => 07723500 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Immunostimulatory nucleic acid molecules' [patent_app_type] => utility [patent_app_number] => 11/503483 [patent_app_country] => US [patent_app_date] => 2006-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 21745 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723500.pdf [firstpage_image] =>[orig_patent_app_number] => 11503483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 579055 [patent_doc_number] => 07456259 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-25 [patent_title] => 'Cancerous disease modifying antibodies' [patent_app_type] => utility [patent_app_number] => 11/496678 [patent_app_country] => US [patent_app_date] => 2006-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12514 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/456/07456259.pdf [firstpage_image] =>[orig_patent_app_number] => 11496678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5050883 [patent_doc_number] => 20070031428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Cancerous disease modifying antibodies' [patent_app_type] => utility [patent_app_number] => 11/496669 [patent_app_country] => US [patent_app_date] => 2006-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12925 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20070031428.pdf [firstpage_image] =>[orig_patent_app_number] => 11496669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 579040 [patent_doc_number] => 07456258 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-25 [patent_title] => 'Cancerous disease modifying antibodies' [patent_app_type] => utility [patent_app_number] => 11/496392 [patent_app_country] => US [patent_app_date] => 2006-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12458 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/456/07456258.pdf [firstpage_image] =>[orig_patent_app_number] => 11496392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5050880 [patent_doc_number] => 20070031425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Cancerous disease modifying antibodies' [patent_app_type] => utility [patent_app_number] => 11/496390 [patent_app_country] => US [patent_app_date] => 2006-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11981 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20070031425.pdf [firstpage_image] =>[orig_patent_app_number] => 11496390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5050882 [patent_doc_number] => 20070031427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Cancerous disease modifying antibodies' [patent_app_type] => utility [patent_app_number] => 11/496457 [patent_app_country] => US [patent_app_date] => 2006-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13495 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20070031427.pdf [firstpage_image] =>[orig_patent_app_number] => 11496457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5159432 [patent_doc_number] => 20070172476 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'Method of treating B-cell neoplasms or Hodgkin\'s lymphoma' [patent_app_type] => utility [patent_app_number] => 11/494499 [patent_app_country] => US [patent_app_date] => 2006-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17310 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20070172476.pdf [firstpage_image] =>[orig_patent_app_number] => 11494499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5204525 [patent_doc_number] => 20070026006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Method of treating cancer cells to create a modified cancer cell that provokes an immunogenic response' [patent_app_type] => utility [patent_app_number] => 11/493936 [patent_app_country] => US [patent_app_date] => 2006-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14855 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20070026006.pdf [firstpage_image] =>[orig_patent_app_number] => 11493936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7688927 [patent_doc_number] => 20070105771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Anti-CD26 antibodies and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/492498 [patent_app_country] => US [patent_app_date] => 2006-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 46206 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105771.pdf [firstpage_image] =>[orig_patent_app_number] => 11492498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 289145 [patent_doc_number] => 07547760 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-16 [patent_title] => 'Peptides and chemical compound for inhibition of SHP2 function' [patent_app_type] => utility [patent_app_number] => 11/480814 [patent_app_country] => US [patent_app_date] => 2006-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9018 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/547/07547760.pdf [firstpage_image] =>[orig_patent_app_number] => 11480814 [rel_patent_id] =>[rel_patent_doc_number] =>)